GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson ...

The companies have identified an initial set of genetic biomarkers to predict drug response and will validate the findings in ...

Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...

At a White House event Thursday, President Trump announced deals with drugmakers Novo Nordisk and Eli Lilly to offer their popular GLP-1 obesity and diabetes drugs at lower prices for some Americans, ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. It makes my head spin to think about how much GLP-1s ...

MIAMI — When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The relentless cravings subsided — only they’d never been for food. The ...

In new research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May), a global panel ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Weight loss drugs like GLP-1s are rapidly reshaping how Americans think about appetite, health and food – forcing CPG brands to reconsider everything from formulation to front-of-pack messaging.

Back in December, 12 mg retatrutide was linked to an efficacy estimand weight loss of 28.7%—and a 75.8% reduction in pain ...

McDonald’s signaled this week it’s looking to better cater to customers on weight-loss drugs — and the name of the game is protein. During a Wednesday earnings call, McDonald’s CEO Chris Kempczinski ...